#Spain #Madrid #SteriLance #Onestep #SoftSense

Introduction

SteriLance Medical, a prominent name in personal blood-sampling solutions, has officially debuted its cutting-edge Onestep™ lancing device along with the SoftSense™ lancets in Spain. This launch marks SteriLance’s strategic foray into the European market and promises to transform the way diabetes patients conduct their daily blood sampling.

The Innovation Behind Onestep

The Onestep device is touted as the world's first cap-free lancing pen, designed to simplify the blood sampling process significantly. By utilizing a unique Total Path Control™ (TPC) vertical-drive technology, Onestep guarantees a seamless, virtually painless experience for users.

Key Features

• - Cap-Free Design: Unlike conventional lancing pens that require the removal of a cap, Onestep eliminates this step entirely. Users merely twist to load the SoftSense lancet, streamlining the workflow.
• - Four-Step Process: The device operates through an intuitive four-step process: insert, twist, press, and eject. This is a staggering 70% reduction in actions required compared to traditional models, making it user-friendly.
• - Pain Reduction: The TPC™ technology ensures that the needle follows a straight path, minimizing vibration and trauma to the tissue, which results in an almost painless experience. Reports from a group of 30 testers showed that 92% experienced little to no pain, with 87% feeling safer thanks to the concealed needle.

Addressing Diabetes in Spain

Spain has a significant population of diabetes sufferers, with approximately 5.1 million adults affected by this condition. This makes it one of the countries with the highest diabetes prevalence rates in Europe. The introduction of the Onestep lancing device is expected to enhance adherence to daily self-monitoring among patients, which is vital for effective diabetes management.

Availability

SteriLance has made the Onestep and SoftSense devices available for purchase in Spain through selected pharmacies and e-commerce platforms. The company plans to expand its distribution to other European markets in the coming months, promising broader accessibility to this innovative product.

Quality Assurance

Both Onestep and SoftSense products are CE-MDR and ISO 13485 certified, ensuring they meet high standards suitable for frequent home-based capillary sampling. This certification enhances consumer confidence in the product's safety and effectiveness.

Conclusion

The launch of the Onestep and SoftSense in Spain not only represents a significant milestone for SteriLance Medical but also offers a promising solution for diabetes patients seeking easier and less painful blood sampling options. As awareness of diabetes grows, devices like Onestep can play a crucial role in helping individuals maintain better control of their health and well-being.

For more information about the Onestep device, visit SteriLance official website.

For media inquiries, contact: [email protected]